ANDA 64146, held by Hospira. Amikacin Sulfate.
As of Nov 16, 2026, ANDA 64146 (Amikacin Sulfate In Sodium Chloride 0.9% In Plastic Container), held by Hospira, was first approved by FDA on Apr 2, 1997, with 2 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Apr 2, 1997 | Original application | Approved |
| Product | Active ingredient | Marketing |
|---|---|---|
| Amikacin Sulfate In Sodium Chloride 0.9% In Plastic ContainerEQ 500MG BASE/100ML ยท injectable;injection | Amikacin Sulfate | Discontinued |
| Feb 22, 1999 | Supplement 1Manufacturing | Approved | None posted |
| Dec 1, 1998 | Supplement 2Manufacturing | Approved | None posted |
| Apr 2, 1997 | Original application | Approved |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters